Developing a vaccine for parvovirus B19
Task V06: Process development and manufacture of cGMP compliant parvovirus B19 vaccine drug product for use in Phase I/II clinical trials
['FUNDING_OTHER'] · ADVANCED BIOSCIENCE LABORATORIES, INC. · NIH-10001092
This study is working on creating a vaccine to help protect people from parvovirus B19, which can lead to serious health problems, and it's designed for those who might benefit from this protection.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ADVANCED BIOSCIENCE LABORATORIES, INC. (nih funded) |
| Locations | 1 site (KENSINGTON, UNITED STATES) |
| Trial ID | NIH-10001092 on ClinicalTrials.gov |
What this research studies
This research focuses on the development and manufacturing of a vaccine for parvovirus B19, which is an infectious disease. The project involves creating a drug product that meets stringent cGMP compliance for use in early-phase clinical trials. Patients may benefit from the vaccine as it aims to provide protection against parvovirus B19, which can cause serious health issues. The research includes thorough planning, optimization, and regulatory support to ensure the vaccine's safety and efficacy.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of parvovirus B19 infection, including those with weakened immune systems or certain blood disorders.
Not a fit: Patients who are already immune to parvovirus B19 or those with unrelated health conditions may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new vaccine that protects against parvovirus B19, potentially reducing the incidence of related infections.
How similar studies have performed: Other vaccine development efforts have shown success in similar approaches, indicating a promising potential for this research.
Where this research is happening
KENSINGTON, UNITED STATES
- ADVANCED BIOSCIENCE LABORATORIES, INC. — KENSINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FOUTS, TIMOTHY — ADVANCED BIOSCIENCE LABORATORIES, INC.
- Study coordinator: FOUTS, TIMOTHY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Communicable Diseases, Infectious Disorder, Infectious Diseases, Infectious Disease Pathway